| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.009 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |